Table 2.
Utilization of endoscopic surveillance in patients with Barrett’s esophagus, stratified by study site.
Variable | Overall n=235 |
Mayo n=79 |
SAVAMC n=75 |
UNC n=81 |
---|---|---|---|---|
Years with BE (mean ± SD) | 6.5 ± 5.9 | 5.2 ± 5.4 | 9.3 ± 6.2 | 5.2 ± 5.2 |
Endoscopy after BE diagnosis | ||||
Yes (n (%)) | 211 (92.1) | 68 (87.2) | 69 (94.5) | 74 (94.9) |
No (n (%)) | 18 (7.9) | 10 (12.8) | 4 (5.5) | 4 (5.1) |
Total surveillance endoscopies (mean ± SD) | 4.0 ± 4.0 | 3.1 ± 2.8 | 5.3 ± 5.1 | 3.8 ± 3.7 |
Months per endoscopy (mean ± SD) | 20.2 ± 16.8 | 20.9 ± 18.6 | 25.4 ± 14.2 | 14.3 ± 15.5 |
Surveillance endoscopies per 2 year period† (mean ± SD) | 1.8 ± 1.7 | 1.5 ± 1.0 | 1.1 ± 0.7 | 2.8 ± 2.5 |
Surveillance endoscopies per 3 year period† (mean ± SD) | 2.7 ± 2.6 | 2.2 ± 1.5 | 1.7 ± 1.0 | 4.2 ± 3.7 |
>1 endoscopic surveillance per 2 year period†‡ (n (%)) | 70 (44.9) | 20 (37.7) | 16 (29.6) | 34 (69.4) |
>1 endoscopic surveillance per 3 year period†‡ (n (%)) | 102 (65.4) | 30 (56.6) | 31 (57.4) | 41 (83.7) |
Patients with BE<6 months were excluded from these analyses.
Discounting a single confirmatory endoscopy following BE diagnosis
Mayo: Mayo Clinic, Rochester, MN; SAVAMC: Southern Arizona VA medical Center, Tucson AZ; UNC: University of North Carolina Hospitals, Chapel Hill, NC
BE=Barrett’s esophagus
SD=standard deviation